Capital Research Global Investors Gilead Sciences, Inc. Transaction History

Capital Research Global Investors

$428 Billion
Q1 2024

A detailed history of Capital Research Global Investors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 61,246,366 shares of GILD stock, worth $4.22 Billion. This represents 1.05% of its overall portfolio holdings.

Number of Shares

61,246,366

Previous 59,657,126 2.66%

Holding current value

$4.22 Billion

Previous $4.83 Billion 7.17%

% of portfolio

1.05%

Previous 1.22%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $114 Million - $139 Million	1,589,240 Added 2.66%	61,246,366 $4.49 Billion
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $128 Million - $145 Million	1,743,418 Added 3.01%	59,657,126 $4.83 Billion
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1.04 Million - $1.13 Million	14,039 Added 0.02%	57,913,708 $4.34 Billion
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $28.8 Million - $32.8 Million	-378,438 Reduced 0.65%	57,899,669 $4.46 Billion
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $284 Million - $324 Million	3,675,155 Added 6.73%	58,278,107 $4.84 Billion

Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $45.3 Million - $65.1 Million	727,482 Added 1.35%	54,602,952 $4.69 Billion
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $125 Million - $143 Million	-2,100,510 Reduced 3.75%	53,875,470 $3.32 Billion
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $1.42 Million - $1.6 Million	24,601 Added 0.04%	55,975,980 $3.46 Billion
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $2.97 Billion - $3.72 Billion	-51,205,602 Reduced 47.79%	55,951,379 $3.33 Billion
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $480 Million - $544 Million	-7,391,127 Reduced 6.45%	107,156,981 $7.78 Billion
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $144 Million - $155 Million	-2,123,447 Reduced 1.82%	114,548,108 $8 Billion
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $377 Million - $412 Million	-5,934,783 Reduced 4.84%	116,671,555 $8.03 Billion
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $56 Million - $63.9 Million	933,939 Added 0.77%	122,606,338 $7.92 Billion
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $258 Million - $294 Million	4,559,152 Added 3.89%	121,672,399 $7.09 Billion
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $512 Million - $644 Million	-8,243,635 Reduced 6.58%	117,113,247 $7.4 Billion
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $2.12 Billion - $2.47 Billion	29,374,563 Added 30.6%	125,356,882 $9.64 Billion
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $680 Million - $870 Million	10,849,434 Added 12.74%	95,982,319 $7.18 Billion
Q4 2019 Feb 18, 2020	BUY	$61.62 - $67.78 $514 Million - $566 Million	8,343,863 Added 10.87%	85,132,885 $5.53 Billion
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $310 Million - $342 Million	-4,959,665 Reduced 6.07%	76,789,022 $4.87 Billion
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $220 Million - $247 Million	3,562,752 Added 4.56%	81,748,687 $5.52 Billion
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $352 Million - $395 Million	5,637,146 Added 7.77%	78,185,935 $5.08 Billion
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $163 Million - $213 Million	2,693,821 Added 3.86%	72,548,789 $4.54 Billion
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $914 Million - $1.01 Billion	12,818,301 Added 22.47%	69,854,968 $5.39 Billion
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $914 Million - $1.07 Billion	14,093,328 Added 32.82%	57,036,667 $4.04 Billion
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $774 Million - $943 Million	10,620,098 Added 32.86%	42,943,339 $3.24 Billion
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $744 Million - $873 Million	10,454,610 Added 47.81%	32,323,241 $2.32 Billion
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.58 Billion - $1.87 Billion	21,868,631	21,868,631 $1.77 Billion

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86.3B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Gilead Sciences, Inc. Transaction History